Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Abroad (travel likely)Recruiting

Conditions

Bipolar Disorder (BD) · Major Depressive Episode (MDE) · Primary Care · Major Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Montpellier, Montpellier, France
Contact: Study coordinator (Raoul BELZEAUX) · raoul.belzeaux@chu-montpellier.fr · +330467337913

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder

Borderline Personality Disorder · Borderline Personality Disorder (BPD) · Bipolar Disorder (BD)

Abroad (travel likely)Recruiting

Montpellier, France

Time Restricted Eating (TRE) in Bipolar Disorder

Bipolar Disorder (BD) · Bipolar Disorder Depression · Overweight (BMI > 30)

Abroad (travel likely)Recruiting

Boston, United States

Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy

Depression - Major Depressive Disorder · Bipolar Disorder (BD) · Functional Magnetic Resonance Imaging (fMRI)

Abroad (travel likely)Recruiting

Frederiksberg, Denmark

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

Bipolar Disorder (BD) · Bipolar Disorder I or II · Bipolar Disorder Family Members

Abroad (travel likely)Recruiting

Dallas, United States